The Protective Effect of Epigallocatechin-3 Gallate on Ischemia/Reperfusion Injury in Isolated Rat Hearts: An ex vivo Approach.
10.4196/kjpp.2011.15.5.259
- Author:
Cheng Shi PIAO
1
;
Do Sung KIM
;
Ki Chan HA
;
Hyung Ryong KIM
;
Han Jung CHAE
;
Soo Wan CHAE
Author Information
1. Department of Pharmacology and Cardiovascular Research Institute, School of Medicine, Chonbuk National University, Jeonju 560-182, Korea. hjchae@jbnu.ac.kr
- Publication Type:Original Article
- Keywords:
Epigallocatechin-3 gallate;
Ischemia/reperfusion injury;
Apoptosis;
Antioxidant
- MeSH:
Animals;
Apoptosis;
Blood Pressure;
Caspase 3;
Catalase;
Heart;
Heart Diseases;
Hemodynamics;
Ischemia;
L-Lactate Dehydrogenase;
Rats;
Reperfusion;
Superoxide Dismutase
- From:The Korean Journal of Physiology and Pharmacology
2011;15(5):259-266
- CountryRepublic of Korea
- Language:English
-
Abstract:
The aim of this study was to evaluate the preventive role of epigallocatechin-3 gallate (EGCG, a derivative of green tea) in ischemia/reperfusion (I/R) injury of isolated rat hearts. It has been suggested that EGCG has beneficial health effects, including prevention of cancer and heart disease, and it is also a potent antioxidant. Rat hearts were subjected to 20 min of normoxia, 20 min of zero-flow ischemia and then 50 min of reperfusion. EGCG was perfused 10 min before ischemia and during the whole reperfusion period. EGCG significantly increased left ventricular developed pressure (LVDP) and increased maximum positive and negative dP/dt (+/-dP/dtmax). EGCG also significantly increased the coronary flow (CF) at baseline before ischemia and at the onset of the reperfusion period. Moreover, EGCG decreased left ventricular end diastolic pressure (LVEDP). This study showed that lipid peroxydation was inhibited and Mn-SOD and catalase expressions were increased in the presence of EGCG. In addition, EGCG increased levels of Bcl-2, Mn-superoxide dismutase (SOD), and catalase expression and decreased levels of Bax and increased the ratio of Bcl-2/Bax in isolated rat hearts. Cleaved caspase-3 was decreased after EGCG treatment. EGCG markedly decreased the infarct size while attenuating the increase in lactate dehydrogenase (LDH) levels in the effluent. In summary, we suggest that EGCG has a protective effect on I/R-associated hemodynamic alteration and injury by acting as an antioxidant and anti-apoptotic agent in one.
